-
Portrait | 2022.06.24
Sandrine Etienne-Manneville: a strong-minded woman tackling brain cancer head on
It's a day of strikes in Paris and the French capital is virtually paralyzed, but it will take more than that to stop Sandrine Etienne-Manneville from arriving on time to explain her scientific research.She's an old hand at this kind of thing and is enthusiastic as she presents the research she leads with her team in the Cell Polarity, Migration and Cancer Unit.Learning from others and teaching...
-
News | 2022.07.01
Monitoring and early warning: Pasteur Center in Cameroon plays an active role in the response to SARS-CoV-2 virus
As a first-line laboratory in the event of a health emergency, the Pasteur Center in Cameroon was naturally designated as a COVID-19 reference laboratory by the Cameroon health authorities in 2020. How did the Pasteur Center in Cameroon organize its response to this emerging novel virus at national level throughout the epidemic, and how is it monitoring the virus today?At the beginning of the...
-
News | 2022.06.27
The Institut Pasteur and the Institut Curie sign a new strategic agreement that holds great potential for French research
The Institut Pasteur and the Institut Curie have embarked on a new collaborative research strategy. A framework agreement was signed on June 22, 2022 between Professor Sir Stewart Cole, President of the Institut Pasteur, and Professor Thierry Philip, Chairman of the Institut Curie's Executive Board. The aim is to push the boundaries of knowledge in cancer cell biology, immunology and human...
-
News | 2022.07.11
How ‘death’ molecules squeeze the cells out of our tissues
Most of our tissues are constantly renewed and needs to get rid of dying cells without affecting their organisation. A newly identified mechanism is responsible for the seamless exclusion of dying cells from our tissues. This process is based on the dismantling of microtubules, long fibers well known for their function during cell division and transport in the cells. Tuning microtubules stability...
-
Document de presse | 2022.06.29
Rethinking the rabies vaccine
Rabies virus kills over 50,000 people each year. Although current rabies vaccines are effective, they do not offer lifelong protection and booster doses are required. Institut Pasteur scientists, in collaboration with researchers from La Jolla Institute for Immunology (LJI) in the United States, captured new high-resolution views of rabies virus, revealing potential vaccine targets. These...
-
Document de presse | 2022.07.13
Light shed on SARS-CoV-2 replication in bat cells
Bats are reservoir species for numerous viruses including coronaviruses. Given that they do not appear to be affected by diseases transmitted by these viruses, there is potential benefit in understanding how their immune system regulates infection. Scientists at the Institut Pasteur and the CNRS studied SARS-CoV-2 replication in bat cells, which involved using real-time imaging techniques for the...
-
News | 2022.07.19
A successful first edition of Pasteur Innov Day
The first Pasteur Innov Day, held on campus on July 7 and organized by the Department of Technology, the Technology Transfer and Industrial Partnership Department (DARRI) and the management team at the institut Pasteur Microbes & Santé, was attended by around a hundred industrial and academic partners. "There is no innovation without technology" was the motto of a day that provided plenty of...
-
Document de presse | 2022.07.21
SARS-CoV-2 hijacks nanotubes between neurons to infect them
COVID-19 often leads to neurological symptoms, such as a loss of taste or smell, or cognitive impairments (including memory loss and concentration difficulties), both during the acute phase of the disease and over the long term with "long COVID" syndrome. But the way in which the infection reaches the brain was previously unknown. Scientists from Institut Pasteur and CNRS laboratories have used...
-
Document de presse | 2022.07.22
Meningref trial shows better protection against meningococcal infection in hematopoietic stem cell transplant recipients
The team in the Hematology Department at Henri Mondor AP-HP Hospital, coordinated by Dr. Christine Robin, and scientists from the Institut Pasteur (the Invasive Bacterial Infections Unit led by Professor Muhamed-Kheir Taha) recently studied protection against meningococcal infection in patients who had received hematopoietic stem cell transplantation.The results of this trial (NCT03509051),...
-
News | 2022.08.24
ZIKAlliance project: Zika vector competence data reveals risks of outbreaks
A publication published this summer looks back at the contribution of the European ZIKAlliance project, launched in 2016 following the Zika epidemic in the Pacific Islands and America. A global analysis of the competence of potential vectors was carried out, the most comprehensive study of vector competence to date using the same protocols. This study reminds us that vector-borne diseases are...
